Evidence map›Paper›PMID 27936035›Full record

ArticlePloS one2016

Natural Endogenous Human Matriptase and Prostasin Undergo Zymogen Activation via Independent Mechanisms in an Uncoupled Manner.

Hui Chen Su, Yan A Liang, Ying-Jung J Lai, Yi-Lin Chiu, Robert B Barndt, Frank Shiao, Hsiang-Hua D Chang, Dajun D Lu, Nanxi Huang, Chun-Che Tseng and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Hui Chen SuDepartment of Pharmacy, Chi-Mei Medical Center, Tainan, Taiwan.
Yan A LiangLombardi Comprehensive Cancer Center, Department of Oncology Georgetown University, Washington DC, United States of America.
Ying-Jung J LaiLombardi Comprehensive Cancer Center, Department of Oncology Georgetown University, Washington DC, United States of America.
Yi-Lin ChiuLombardi Comprehensive Cancer Center, Department of Oncology Georgetown University, Washington DC, United States of America.
Robert B BarndtLombardi Comprehensive Cancer Center, Department of Oncology Georgetown University, Washington DC, United States of America.
Frank ShiaoLombardi Comprehensive Cancer Center, Department of Oncology Georgetown University, Washington DC, United States of America.
Hsiang-Hua D ChangLombardi Comprehensive Cancer Center, Department of Oncology Georgetown University, Washington DC, United States of America.
Dajun D LuLombardi Comprehensive Cancer Center, Department of Oncology Georgetown University, Washington DC, United States of America.
Nanxi HuangLombardi Comprehensive Cancer Center, Department of Oncology Georgetown University, Washington DC, United States of America.
Chun-Che TsengLombardi Comprehensive Cancer Center, Department of Oncology Georgetown University, Washington DC, United States of America.
Jehng-Kang WangDepartment of Biochemistry, National Defense Medical Center, Taipei, Taiwan.
Ming-Shyue LeeGraduate Institute of Biochemistry and Molecular Biology, College of Medicine National Taiwan University, Taipei, Taiwan.
Michael D JohnsonLombardi Comprehensive Cancer Center, Department of Oncology Georgetown University, Washington DC, United States of America.
Shih-Ming HuangDepartment of Biochemistry, National Defense Medical Center, Taipei, Taiwan.
Chen-Yong LinLombardi Comprehensive Cancer Center, Department of Oncology Georgetown University, Washington DC, United States of America.
Georgetown University · USGeorgetown University Medical Center · USNational Defense Medical Center · TWChi Mei Medical Center · TWNational Taiwan University · TW

Funding

Tissue Culture Shared ResourceP30CA051008 · NCI · GEORGETOWN UNIVERSITY · PI STEPHEN W BYERS · 1990 to 2026
$71.5M
Mechanisms of Deregulation of Matriptase in Breast CancerR01CA123223 · NCI · GEORGETOWN UNIVERSITY · PI JOHNSON, MICHAEL D, LIN, CHEN-YONG · 2010 to 2014
$1.6M
NCI NIH HHS P30 CA051008NCI NIH HHS R01 CA123223
6 · The paper itself

Abstract

The membrane-associated serine proteases matriptase and prostasin are believed to function in close partnership. Their zymogen activation has been reported to be tightly coupled, either as a matriptase-initiated proteolytic cascade or through a mutually dependent mechanism involving the formation of a reciprocal zymogen activation complex. Here we show that this putative relationship may not apply in the context of human matriptase and prostasin. First, the tightly coupled proteolytic cascade between matriptase and prostasin might not occur when modest matriptase activation is induced by sphingosine 1-phospahte in human mammary epithelial cells. Second, prostasin is not required and/or involved in matriptase autoactivation because matriptase can undergo zymogen activation in cells that do not endogenously express prostasin. Third, matriptase is not required for and/or involved in prostasin activation, since activated prostasin can be detected in cells expressing no endogenous matriptase. Finally, matriptase and prostasin both undergo zymogen activation through an apparently un-coupled mechanism in cells endogenously expressing both proteases, such as in Caco-2 cells. In these human enterocytes, matriptase is detected primarily in the zymogen form and prostasin predominantly as the activated form, either in complexes with protease inhibitors or as the free active form. The negligible levels of prostasin zymogen with high levels of matriptase zymogen suggests that the reciprocal zymogen activation complex is likely not the mechanism for matriptase zymogen activation. Furthermore, high level prostasin activation still occurs in Caco-2 variants with reduced or absent matriptase expression, indicating that matriptase is not required and/or involved in prostasin zymogen activation. Collectively, these data suggest that any functional relationship between natural endogenous human matriptase and prostasin does not occur at the level of zymogen activation.

Indexed as

Cell Line, TumorEnzyme ActivationEnzyme PrecursorsHumansProstasinSerine EndopeptidasesEnzyme PrecursorsmatriptaseProstasinSerine Endopeptidases

Identifiers

PMID27936035
PMCPMC5148038
OpenAlexW2559913574

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.